A Parallel-arm, Double-blind, Randomized, Placebo-controlled, Dose-ranging Clinical Trial Evaluating the Safety, Tolerability and Immunogenicity of AV7909 in Healthy Adults

Trial Profile

A Parallel-arm, Double-blind, Randomized, Placebo-controlled, Dose-ranging Clinical Trial Evaluating the Safety, Tolerability and Immunogenicity of AV7909 in Healthy Adults

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Oct 2014

At a glance

  • Drugs AV 7909 (Primary) ; Anthrax vaccine
  • Indications Anthrax
  • Focus Adverse reactions
  • Sponsors Emergent BioSolutions
  • Most Recent Events

    • 13 Feb 2014 Results published in the Vaccine.
    • 20 Aug 2012 Actual end date (June 2012) added as reported by ClinicalTrials.gov.
    • 01 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top